What the Research Says About Acupressure

Acupressure, which involves applying pressure to specific points on the body, has been studied extensively for nausea and vomiting across various medical conditions. The evidence is particularly strong for a point called P6 (also known as Neiguan or Pericardium 6), located on the inner wrist.

A 2011 systematic review by Lee and Frazier examined randomized controlled trials of acupressure for symptom management and found that 84 percent of investigators concluded acupressure was effective. The technique showed promise for managing pain, nausea, and other symptoms across different patient populations. For nausea specifically, multiple Cochrane reviews have evaluated P6 stimulation. In postoperative settings with over 3,000 patients studied, P6 stimulation showed consistent effectiveness in reducing both nausea and vomiting. For chemotherapy-induced nausea, studies with more than 1,200 patients found that acupressure was effective for first-day nausea.

The mechanism appears to involve regulating gastrointestinal motility, inhibiting gastric acid secretion, and modulating the autonomic nervous system. When P6 is stimulated, it affects endocrine function and helps adjust how the digestive system responds to triggers that cause nausea.

While specific research on acupressure in CF populations remains limited, one pilot study examined acupuncture (which works on similar principles to acupressure) for pain management in CF patients. The study found acupuncture effective in decreasing pain complaints with no reported side effects. Given that nausea and digestive discomfort are common in CF, and the broader evidence supports acupressure’s safety and effectiveness, this technique may offer value for CF patients managing gastrointestinal symptoms.